Lazertinib(Leclaza)

Another NameLuciLazer、Leclaza

IndicationsIt is indicated for the first-line treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) exon 19 deletion